Search

Your search keyword '"HERPESVIRUS disease treatment"' showing total 423 results

Search Constraints

Start Over You searched for: Descriptor "HERPESVIRUS disease treatment" Remove constraint Descriptor: "HERPESVIRUS disease treatment"
423 results on '"HERPESVIRUS disease treatment"'

Search Results

1. Diagnosis and treatment of pseudorabies virus infectious encephalitis in human.

2. Elsberg Syndrome with Mixed Presentation as Meningitis Retention Syndrome: A Pediatric Case Report and Comprehensive Review of the Literature.

3. Herpes Virus, Causes of Infections and Preventive Methods.

4. A knockdown of the herpes simplex virus type-1 gene in all-in-one CRISPR vectors.

5. Virucidal activity of ginger essential oil against caprine alphaherpesvirus-1.

6. Resurgence of Salmonid Herpesvirus‐3 Infection (Epizootic Epitheliotropic Disease) in Hatchery‐Propagated Lake Trout in Michigan.

7. Oncogenic Kaposi's Sarcoma-Associated Herpesvirus Upregulates Argininosuccinate Synthase 1, a Rate-Limiting Enzyme of the Citrulline-Nitric Oxide Cycle, To Activate the STAT3 Pathway and Promote Growth Transformation.

8. Clinicopathology conference: 41-year-old woman with chronic relapsing meningitis.

9. Human Herpesvirus 6B in the Transplant Recipient: When to Worry, When to Act.

10. Antiviral efficacy of the helicase-primase inhibitor amenamevir in murine models of severe herpesvirus infection.

11. The Treatment of Herpetic Infections: State of the Art.

13. Role of Pattern Recognition Receptors in KSHV Infection.

14. Radiotherapy-induced reactivation of neurotrophic human herpes viruses: Overview and management.

15. Correlation between HPV status at T and N sites of oropharyngeal squamous cell carcinomas.

16. Biophysical and In Silico Studies of the Interaction between the Anti-Viral Agents Acyclovir and Penciclovir, and Human Serum Albumin.

17. The Secret Powers of RNA.

18. Use of whole genome deep sequencing to define emerging minority variants in virus envelope genes in herpesvirus treated with novel antimicrobial K21.

20. Peptides Derived from Glycoproteins H and B of Herpes Simplex Virus Type 1 and Herpes Simplex Virus Type 2 Are Capable of Blocking Herpetic Infection in vitro.

21. Kaposi's Sarcoma-Associated Herpesvirus Infection of Neurons in HIV-Positive Patients.

22. Glycolysis, Glutaminolysis, and Fatty Acid Synthesis Are Required for Distinct Stages of Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication.

23. Integrated systems biology analysis of KSHV latent infection reveals viral induction and reliance on peroxisome mediated lipid metabolism.

24. Profile of anti-herpetic action of ASP2151 (amenamevir) as a helicase-primase inhibitor.

25. CRISPR/Cas9, a powerful tool to target human herpesviruses.

26. Effect of Pritelivir Compared With Valacyclovir on Genital HSV-2 Shedding in Patients With Frequent Recurrences: A Randomized Clinical Trial.

27. Altering the Anti-inflammatory Lipoxin Microenvironment: a New Insight into Kaposi's Sarcoma-Associated Herpesvirus Pathogenesis.

28. CD4+ T Cells Coexpressing CD134 (OX40) Harbor Significantly Increased Levels of Human Herpesvirus 6B DNA Following Umbilical Cord Blood Transplantation.

29. Azidothymidine Sensitizes Primary Effusion Lymphoma Cells to Kaposi Sarcoma-Associated Herpesvirus-Specific CD4+ T Cell Control and Inhibits vIRF3 Function.

30. Occurrence of OsHV-1 in Crassostrea gigas Cultured in Ireland during an Exceptionally Warm Summer. Selection of Less Susceptible Oysters.

31. Potential Adverse Outcomes of Gene Therapy.

32. Oral administration of famciclovir for treatment of spontaneous ocular, respiratory, or dermatologic disease attributed to feline herpesvirus type I:59 cases (2006-2013).

33. 3,19-isopropylideneandrographolide suppresses early gene expression of drug-resistant and wild type herpes simplex viruses.

34. Targeting the pseudorabies virus DNA polymerase processivity factor UL42 by RNA interference efficiently inhibits viral replication.

35. Herpesvirus Late Gene Expression: A Viral-Specific Pre-initiation Complex Is Key.

36. Cytomegalovirus persistence and T-cell immunosenescence in people aged fifty and older: A systematic review.

37. Inhibition of herpes virus infection in oligodendrocyte cultured cells by valproic acid.

38. Murine Gammaherpesvirus 68 LANA and SOX Homologs Counteract ATM-Driven p53 Activity during Lytic Viral Replication.

39. Antiviral agents against equid alphaherpesviruses: Current status and perspectives.

40. Exogenous human herpesvirus 6 reinfection after tumor-infiltrating T-lymphocyte therapy.

41. Herpes simplex virus type 2 infection induces AD-like neurodegeneration markers in human neuroblastoma cells.

42. Synthesis and biological evaluation of new nucleosides derived from trifluoromethoxy-4-quinolones.

43. Broad-spectrum non-nucleoside inhibitors of human herpesviruses.

44. Human herpesvirus-6 infection-associated acute encephalopathy without skin rash.

45. ORF45-Mediated Prolonged c-Fos Accumulation Accelerates Viral Transcription during the Late Stage of Lytic Replication of Kaposi's Sarcoma-Associated Herpesvirus.

46. Herpes Viral Origin of the Parsonage-Turner Syndrome: Highlighting of Serological Immune Anti-Herpes Deficiency Cured by Anti-Herpes Therapy.

47. HERPES VIRUS, HUMAN PAPILLOMA VIRUS AND POLYOMAVIRUS INFECTION IN PATIENTS UNDERGOING BIOLOGICAL THERAPY.

48. Varicella zoster virus reactivation after autologous SCT is a frequent event and associated with favorable outcome in myeloma patients.

49. Prevalence of canid herpesvirus-1 infection in stillborn and dead neonatal puppies in Denmark.

50. Detection of HHV-6-specific mRNA and antigens in PBMCs of individuals with chromosomally integrated HHV-6 (ciHHV-6).

Catalog

Books, media, physical & digital resources